Shares in Sorrento (SRNE) are rallying 17% in Thursday’s pre-market trading after the company announced that an Application for Emergency Use Authorization (EUA) …
If the current state of the market dictates that the new normal involves almost daily swings of extreme volatility, the wild activity is considered normal …
In January, Sorrento Therapeutics (SRNE) — a biotech specializing in cancer pain alleviation, but with no profits and only $25 million in trailing …
Sorrento Therapeutics (SRNE) started the week by following last week’s pattern – rocketing up the charts. Although 25% increase seems like small fry …
Can you feel the ground moving beneath your feet? Shares of Sorrento Therapeutics (SRNE) skyrocketed 70% today after the small drug maker were …
Sorrento Therapeutics (NASDAQ:SRNE) and Celularity announced that the companies have started screening patients for its leading CD38 chimeric antigen receptor (CAR) T cell …
A number of biotech companies, including Sorrento Therapeutics Inc (NASDAQ:SRNE), have staked a lot on CAR-T therapies for cancer patients. Yesterday, Sorrento reported initial results …
Analyst spotlights a compelling commercial future ahead for Sorrento’s ZTlido in post-herpetic neuralgia.
